Novo Holdings A/S’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$44.6M Buy
1,550,000
+275,000
+22% +$7.91M 3.15% 9
2025
Q1
$42.8M Buy
1,275,000
+314,785
+33% +$10.6M 3.25% 10
2024
Q4
$49.1M Sell
960,215
-39,785
-4% -$2.03M 2.97% 11
2024
Q3
$51.1M Hold
1,000,000
2.54% 13
2024
Q2
$44.8M Sell
1,000,000
-98,600
-9% -$4.42M 2.41% 11
2024
Q1
$51.4M Sell
1,098,600
-1,400
-0.1% -$65.5K 3.55% 7
2023
Q4
$39.1M Hold
1,100,000
2.42% 16
2023
Q3
$32.7M Hold
1,100,000
2.42% 18
2023
Q2
$19.8M Hold
1,100,000
1.53% 24
2023
Q1
$17.7M Buy
1,100,000
+362,943
+49% +$5.83M 1.17% 25
2022
Q4
$13.5M Buy
737,057
+105,430
+17% +$1.93M 0.84% 34
2022
Q3
$12.4M Hold
631,627
0.59% 30
2022
Q2
$11.8M Buy
631,627
+206,730
+49% +$3.86M 0.58% 32
2022
Q1
$9.33M Buy
+424,897
New +$9.33M 0.49% 37
2021
Q2
Sell
-271,378
Closed -$4.15M 56
2021
Q1
$4.15M Hold
271,378
0.17% 46
2020
Q4
$3.83M Hold
271,378
0.16% 43
2020
Q3
$4.25M Buy
271,378
+56,925
+27% +$892K 0.21% 41
2020
Q2
$3.76M Buy
214,453
+50,000
+30% +$876K 0.24% 32
2020
Q1
$2.42M Buy
164,453
+29,444
+22% +$433K 0.16% 28
2019
Q4
$3.39M Hold
135,009
0.22% 24
2019
Q3
$2.03M Hold
135,009
0.35% 25
2019
Q2
$3.38M Hold
135,009
0.47% 25
2019
Q1
$3.07M Hold
135,009
0.45% 20
2018
Q4
$4.05M Sell
135,009
-14,991
-10% -$450K 0.57% 20
2018
Q3
$4.3M Buy
+150,000
New +$4.3M 0.34% 21